# Inversion Therapeutics, Inc. — Form D

Inversion Therapeutics, Inc. of BURLINGAME, CA, a company, filed a Form D exempt-offering notice with the SEC on 2025-08-27. The offering totals $11.1M, of which $6.9M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2025-08-27
- Form: D
- Accession: 0001231919-25-000167
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $11.1M
- Amount sold: $6.9M
- Remaining: $4.2M
- Investors: 4
- Date of first sale: 2025-06-20
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-555986

## Issuer

- Name: Inversion Therapeutics, Inc.
- CIK: 0002077706
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2024
- Address: 1341 COLUMBUS AVENUE, BURLINGAME, CA, 94010
- Phone: 650-430-5176

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| Jeremy A Caldwell, Ph.D. | Director | Burlingame, CA |
| William Michael Kavanaugh, M.D. | Director | Burlingame, CA |
| Samad Michael Wahid, M.D. | Director | Burlingame, CA |
| James A Wells, Ph.D. | Director | Burlingame, CA |
| James A Wells, Ph.D. | Executive Officer | Burlingame, CA |

## More

- [CIK 2077706 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2077706&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001231919-25-000167.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.